Early Access — free while we kick the tires
EdgarHawk

BALDWIN JOHN T

Director

Director
2 filings analyzed · 1 company · Latest 2025-03-10

Companies

Company Buys Sells Direction
CLEVELAND-CLIFFS INC. CLF 2 0 Net buying

Activity

March 2025
medium
Buy
4,000 shares
$34,800
Significance 4/10

CLF Director BALDWIN JOHN T buys 4,000 shares at $8.70; stock down 61.7% from 52-week high amid -$242.0M annual loss.

Director John T. Baldwin purchased 4,000 shares of Cleveland-Cliffs Inc. at $8.70 on March 10, 2025, increasing his holdings to 133,227 shares. The purchase occurs as the stock trades 61.7% below its 52-week high of $22.83 and the company reported a net income of -$242.0M over its most recent full fiscal year, with annual revenue declining 12.8% year-over-year. Baldwin's prior two purchases at CLF (August 2024 and June 2024) both resulted in negative 90-day returns (-10.1% and -9.2% respectively), and across his broader insider trading history, his average 90-day return has been -16.8% with a 0.00% win rate. A cluster pattern is present, with two other insiders also purchasing within the past 14 days, though this represents a small absolute position increase of only 3.1% relative to pre-transaction holdings in a company facing sustained profitability challenges.

August 2024
medium
Buy
8,000 shares
$116,240
Significance 4/10

CLF Director Baldwin buys 8,000 shares at $14.53; stock now $14.64, down 35.9% from 52-week high, P/E 162.67.

John T Baldwin, a director at Cleveland-Cliffs Inc., purchased 8,000 shares at $14.53 on 2024-08-01, increasing his holdings by 8,000 shares to 129,227 shares total. The stock currently trades at $14.64, down 35.9% from its 52-week high of $22.83 and down 16.8% over 90 days. Baldwin's prior open-market buy at CLF on 2024-06-13 returned +10.0% at the 30-day mark, though the 90-day outcome is not yet measurable. The company's fundamentals show strained profitability: despite $5.1B in quarterly revenue, net income stands at $2.0M (a compression from operational scale), and annual revenue contracted 4.3% year-over-year, with a notably elevated P/E of 162.67. The timing of this purchase—after a 16.8% decline over three months—coincides with significant stock weakness relative to recent history, though this alone does not confirm directional conviction.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access